Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Munster Study Group

K. Klein, G. Kaspers, C.J. Harrison, HB Beverloo, A. Reedijk, M. Bongers, J. Cloos, A. Pession, D. Reinhardt, M. Zimmerman, U. Creutzig, M Dworzak, T. Alonzo, D. Johnston, B. Hirsch, M. Zapotocky, B. De Moerloose, A. Fynn, V. Lee, T. TagaA. Tawa, A. Auvrignon, B. Zeller, E. Forestier, C. Salgado, W. Balwierz, A. Popa, J. Rubnitz, S. Raimondi, B Gibson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4247-4258
JournalJournal of Clinical Oncology
Volume33
Issue number36
DOIs
Publication statusPublished - 2015

Cite this